MCMedicalCodingSoftware
Free trial
XW14325

XW14325 — Transfusion of Convalescent Plasma (Nonautologous) into Central Vein, Percutaneous Approach, New Technology Group 5

Billable / specific codeICD-10-PCS

CMS abbreviated title: Transfuse Convalesc Plasma in Central Vein, Perc, New Tech 5

How XW14325 is built

Every ICD-10-PCS code is seven independent character positions. Each one is a separate decision, and the meaning of a character depends on the positions before it.

  1. XSectionNew Technology — What family of procedure this is
  2. WBody systemWhich system it acts on
  3. 1Root operationThe objective — the verb of the procedure
  4. 4Body partThe specific site
  5. 3ApproachHow the site was reached
  6. 2DeviceWhat was left in place, if anything
  7. 5QualifierA further distinction where one applies

Codes near XW14325

In CMS’s own ordering, which groups codes that differ by only the last character or two — usually the approach, device or qualifier.

  • XW133D7Transfusion of High-Dose Intravenous Immune Globulin into Peripheral Vein, Percutaneous Approach, New Technology Group 7
  • XW133E7Transfusion of Hyperimmune Globulin into Peripheral Vein, Percutaneous Approach, New Technology Group 7
  • XW133F8Transfusion of OTL-103 into Peripheral Vein, Percutaneous Approach, New Technology Group 8
  • XW133G8Transfusion of Atidarsagene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8
  • XW133H9Transfusion of Lovotibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 9
  • XW133J8Transfusion of Exagamglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8
  • XW133SBTransfusion of Mozafancogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 11
  • XW133YBTransfusion of Nonautologous (Human) Fibrinogen Concentrate, Shelf-stable into Peripheral Vein, Percutaneous Approach, New Technology Group 11
  • XW14325Transfusion of Convalescent Plasma (Nonautologous) into Central Vein, Percutaneous Approach, New Technology Group 5
  • XW1437ATransfusion of Marnetegragene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 10
  • XW143B8Transfusion of Betibeglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8
  • XW143C8Transfusion of Omidubicel into Central Vein, Percutaneous Approach, New Technology Group 8
  • XW143D7Transfusion of High-Dose Intravenous Immune Globulin into Central Vein, Percutaneous Approach, New Technology Group 7
  • XW143E7Transfusion of Hyperimmune Globulin into Central Vein, Percutaneous Approach, New Technology Group 7
  • XW143F8Transfusion of OTL-103 into Central Vein, Percutaneous Approach, New Technology Group 8
  • XW143G8Transfusion of Atidarsagene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8
  • XW143H9Transfusion of Lovotibeglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 9
ICD-10-PCSFY2026